PulseAugur
EN
LIVE 00:50:47

Science Corp implants vision chip in Stargardt patient, eyes broader BCI use

By PulseAugur Editorial · [1 sources] ·

Science Corporation has successfully implanted its PRIMA vision-restoring chip into its first patient suffering from Stargardt disease, an inherited condition causing central vision loss. CEO Max Hodak, formerly of Neuralink, presented this milestone at TechCrunch Disrupt, highlighting the chip's function as artificial photoreceptors and its potential for broader brain-computer interface applications. While PRIMA is already available in Europe for age-related macular degeneration, this trial in Australia marks a significant step towards treating Stargardt disease, with the company aiming for near-native visual acuity within five years. AI

IMPACT This medical device represents a novel application of brain-computer interface technology, potentially expanding its use beyond traditional computing control.

RANK_REASON The article describes the implantation of a medical device, which is a product application rather than a core AI release or research.

Read on TechCrunch AI →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Science Corp implants vision chip in Stargardt patient, eyes broader BCI use

How we ranked this

Signal score
14 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The article describes the implantation of a medical device, which is a product application rather than a core AI release or research.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
product, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Standard
On-topic for AI-industry coverage; kept in the public index.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

Full methodology in our editorial standards.

COVERAGE [1]

  1. TechCrunch AI TIER_1 English(EN) · Aisha Malik ·

    Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

    Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).

RELATED ENTITIES

RELATED TOPICS